Cade, Telix Group Chief Medical Officer, said, “Telix will feature in four presentations at this year’s ASCO GU, which showcase the depth and differentiation of our therapeutic urologic pipeline, ...
On Tuesday, Kate Middleton visited London’s Royal Marsden Hospital, the cancer center where she received treatment after her own diagnosis with the illness last year. Before the princess arrived ...
a professor at The University of Texas MD Anderson Cancer Center in Houston, who was not involved in the new report. This decline in cancer deaths has been largely due to reductions in people ...
The University of Kansas Cancer Center reached a fundraising milestone that will trigger a spring construction start on its $450 million research center. The University of Kansas Cancer Center ...
according to the final results of the phase 3 KATHERINE clinical trial led by researchers from the University of Pittsburgh and UPMC Hillman Cancer Center. KATHERINE is a landmark clinical trial ...
Siteman Cancer Center at Washington University. But too much estrogen over a lifetime can lead to the formation and growth of cancerous cells. Over time, there have been several population-level ...
While the announcement is good news for the Princess of Wales, cancer experts describe the challenges of a life shadowed by an earlier diagnosis. By Gina Kolata Gina Kolata has reported on ...
His wife insisted that he seek a second opinion at Memorial Sloan Kettering Cancer Center in New York City. MSK doctors found that, rather than lymphoma, Wolff had histiocytic sarcoma: a rare ...
Andrea Schietinger of Memorial Sloan Kettering Cancer Center, Weill Cornell Graduate School of Medical Sciences, and Parker Institute for Cancer Immunotherapy; and Mark Sundrud of Dartmouth College.
Kate Middleton confirmed this afternoon that her Cancer is in remission following a stretch of chemotherapy. “It is a relief to now be in remission and I remain focussed on recovery ...
The CU Cancer Center brings together world-class researchers, clinicians, and educators to deliver innovative cancer therapies and shape the future of oncology. As a leader in translational ...